ADMA Biologics CEO Adam S Grossman Sells 21,000 Shares

TradingView
2025.03.22 01:10
portai
I'm PortAI, I can summarize articles.

Reporter NameGrossman Adam SRelationshipPresident and CEOTypeSellAmount$397,320SEC FilingForm 4Adam S Grossman, President and CEO of ADMA Biologics and a Director of the company, sold 21,000 shares of common stock on March 19, 2025, at a price of $18.92 per share, totaling $397,320. Following these transactions, Grossman directly owns 2,061,850 shares and indirectly owns 1,724,383 shares of ADMA Biologics common stock through Areth, LLC and Hariden, LLC.SEC Filing: ADMA BIOLOGICS, INC. [ ADMA ] - Form 4 - Mar. 21, 2025

Reporter NameGrossman Adam S
RelationshipPresident and CEO
TypeSell
Amount$397,320
SEC FilingForm 4

Adam S Grossman, President and CEO of ADMA Biologics and a Director of the company, sold 21,000 shares of common stock on March 19, 2025, at a price of $18.92 per share, totaling $397,320. Following these transactions, Grossman directly owns 2,061,850 shares and indirectly owns 1,724,383 shares of ADMA Biologics common stock through Areth, LLC and Hariden, LLC.

SEC Filing: ADMA BIOLOGICS, INC. [ ADMA ] - Form 4 - Mar. 21, 2025

Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.